Senate Committee on Health, Education, Labor, and Pensions hearing entitled, "The 340B Program: Examining Its Growth and Impact on Patients." Witnesses Include: Michelle Rosenberg, Director, Health Care, U.S. Government Accountability Office, Washington, DC Aditi Sen, Ph.D., Chief, Health Policy Studies Unit, Congressional Budget Office, Washington, DC William B. Feldman, MD, DPhil, MPH, Physician and Health Policy Researcher, University of California October 23, 2025. Support The Union Herald P

Oversight and Investigations Subcommittee Hearing: “Oversight of 340B Drug Pricing Program”

Taxpayers are footing the bill for the 340B Drug Pricing Program. Hospitals, contract pharmacies, and special interest sharks are profiting. They’re taking advantage of 340B discounts meant for patients, and it’s costing taxpayers. We can fix the mess if Congress reforms the program. https://www.cagw.org/340B #Fix340B | Citizens Against Government Waste | Facebook

583 views | Reel by Citizens Against Government Waste